Compounds > 1,3-dipropyl-8-cyclopentylxanthine
Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Diabetes Mellitus, Type 2

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malaisse, WJ1
Lebrun, P1
Pirotte, B1
Van Poelje, PD1
Viñambres, C1
Villanueva-Peñacarrillo, ML1
Valverde, I1
Gäbel, J1
Rorsman, P1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Diabetes Mellitus, Type 2

ArticleYear
The riddle of formycin A insulinotropic action.
    Biochemical and molecular medicine, 1996, Volume: 57, Issue:1

    Topics: Adenosine; Animals; Calcium; Diabetes Mellitus, Type 2; Diazoxide; Female; Formycins; Glucose; Glybu

1996